Evaluation of lidoflazine as an anti-anginal drug.
D000284:Administration, Oral; D000328:Adult; D000787:Angina Pectoris / Q000000981:diagnostic imaging / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D017023:Coronary Angiography; D004341:Drug Evaluation; D005080:Exercise Test; D005260:Female; D006339:Heart Rate; D006801:Humans; D008013:Lidoflazine / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D005996:Nitroglycerin / Q000627:therapeutic use; D010146:Pain / Q000188:drug therapy; D010879:Piperazines / Q000627:therapeutic use*; D010919:Placebos; D013997:Time Factors; D014665:Vasodilator Agents / Q000627:therapeutic use*; D014692:Ventilation-Perfusion Ratio
D010879:Piperazines; D010919:Placebos; D014665:Vasodilator Agents; D005996:Nitroglycerin; D008013:Lidoflazine